LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 98 of 166
Next
>>
>
2426 to 2450 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	XMD16-144	0.12	uM	LJP5	72	hr	1657	3685	5588	0.6595	0.5767
BT-20	XMD16-144	0.37	uM	LJP5	72	hr	1657	2144	5588	0.3837	0.1578
BT-20	XMD16-144	1.11	uM	LJP5	72	hr	1657	1965	5588	0.3516	0.1015
BT-20	XMD16-144	3.33	uM	LJP5	72	hr	1657	1958	5588	0.3504	0.0995
BT-20	XMD16-144	10	uM	LJP5	72	hr	1657	1812	5588	0.3242	0.0513
BT-20	Erlotinib	0.04	uM	LJP5	72	hr	1657	4819	5588	0.8626	0.8379
BT-20	Erlotinib	0.12	uM	LJP5	72	hr	1657	5003	5588	0.8953	0.8778
BT-20	Erlotinib	0.37	uM	LJP5	72	hr	1657	5023	5588	0.8990	0.8819
BT-20	Erlotinib	1.11	uM	LJP5	72	hr	1657	4901	5588	0.8771	0.8557
BT-20	Erlotinib	3.33	uM	LJP5	72	hr	1657	4827	5588	0.8639	0.8398
BT-20	Erlotinib	10	uM	LJP5	72	hr	1657	3520	5588	0.6297	0.5354
BT-20	Gefitinib	0.04	uM	LJP6	72	hr	1657	5762	5383	1.0708	1.0826
BT-20	Gefitinib	0.12	uM	LJP6	72	hr	1657	5388	5383	1.0024	1.0031
BT-20	Gefitinib	0.37	uM	LJP6	72	hr	1657	5237	5383	0.9742	0.9698
BT-20	Gefitinib	1.11	uM	LJP6	72	hr	1657	5052	5383	0.9391	0.9271
BT-20	Gefitinib	3.33	uM	LJP6	72	hr	1657	4857	5383	0.9029	0.8836
BT-20	Gefitinib	10	uM	LJP6	72	hr	1657	4280	5383	0.7955	0.7482
BT-20	Nilotinib	0.04	uM	LJP5	72	hr	1657	5364	5588	0.9598	0.9534
BT-20	Nilotinib	0.12	uM	LJP5	72	hr	1657	5401	5588	0.9666	0.9617
BT-20	Nilotinib	0.37	uM	LJP5	72	hr	1657	5513	5588	0.9865	0.9840
BT-20	Nilotinib	1.11	uM	LJP5	72	hr	1657	5335	5588	0.9547	0.9477
BT-20	Nilotinib	3.33	uM	LJP5	72	hr	1657	5576	5588	0.9977	0.9966
BT-20	Nilotinib	10	uM	LJP5	72	hr	1657	2060	5588	0.3687	0.1314
BT-20	JNK-9L	0.04	uM	LJP6	72	hr	1657	4504	5383	0.8372	0.8010
BT-20	JNK-9L	0.12	uM	LJP6	72	hr	1657	4144	5383	0.7704	0.7156

|<
<<
Previous
Page 98 of 166
Next
>>
>
2426 to 2450 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)